The influence of Covid-19 on eHealth and cross-border
cooperation from the perspective of German and Dutch
The influence of Covid-19 on eHealth and cross-border
cooperation from the perspective of German and Dutch
medical professionals
MASTER’S THESIS
by
Moritz Klitzke
S4162242 / 190548180
15639 words (excluding tables and references)
Abstract
eHealth is an often-treated topic in the literature as well in politics for more than 20 years now,
but the implementation in health care systems is developing slowly. However, during the
current Covid-19 pandemic, eHealth is getting a considerable amount of attention as essential
support to manage the pandemic. Also, cross-border cooperation appears to play a role in the
pandemic management. Therefore, the present study aims to investigate the influence of
Covid-19 on eHealth and cross-border cooperation in German and Dutch health care systems. For this
purpose, eleven stakeholders of the health care system from each country have been
interviewed. The findings show that eHealth has been used more, implementation processes
sped-up and different influencing factors on eHealth acceptance have been identified.
Cross-border cooperation has been determined not to be influenced by Covid-19. Afterwards, the
discussion points out whether this is a long-term opportunity or not and put the findings in
context from an operation- and supply chain management perspective.
1
stSupervisor:
Dr. Esther Metting
Faculty of Economics and Business at
University of Groningen
EBM028A30
2
ndSupervisor:
Dr. Rebecca Casey
Newcastle University Business School at
Newcastle University
Acknowledgement
I would like to express my sincere appreciation to my first supervisor Esther Metting. She
supported me through my research project from the very beginning on with her great expertise.
Without her guidance and her constant feedback for my work, this project would not have been
possible. I am grateful for her extraordinary support.
I wish to extend my special thanks to my second supervisor Rebecca Casey, who showed great
interest in my project. She was always willing to answer my questions. Her insightful feedback
gave me the opportunity to improve my work.
I thank all my interviewees for the valuable insights and information they contributed to this
study. I am thankful that, despite their very stressful day, they still found the time to answer my
questions
Table of Contents
1.
Introduction ... 1
2.
Theoretical Background ... 3
2.1.
Definition ... 3
2.1.1.
eHealth ... 3
2.1.2.
mHealth ... 3
2.1.3.
Wearables ... 4
2.2.
Development of eHealth ... 4
2.3.
The German and Dutch HCS ... 5
2.3.1.
The HCSs of Germany and the Netherlands ... 5
2.3.2.
Progress of eHealth in the HCSs ... 6
2.3.3.
Cross-border cooperation between Germany and the Netherlands ... 7
2.4.
Drivers and barriers of eHealth implementation ... 8
2.5.
eHealth during pandemics ... 9
2.6.
Research objectives ... 10
2.6.1.
The impact of Covid-19 in different countries ... 12
2.7.
Research Questions ... 13
3.
Methodology ... 14
3.1.
Case selection ... 14
3.2.
Data collection ... 15
3.3.
Data analysis method ... 16
3.4.
Validity and reliability ... 18
4.
Findings ... 20
4.1.
eHealth ... 20
4.1.1.
eHealth being offered by MPs ... 20
4.1.1.1.
Experienced change during Covid-19 ... 20
4.1.1.2.
Barriers and improvement potential for eHealth... 21
4.1.3.
Acceptance of eHealth ... 23
4.1.3.1.
Acceptance among patients ... 24
4.1.3.2.
Acceptance among MPs ... 24
4.1.3.3.
Factors influencing the acceptance of eHealth ... 25
4.1.4.
Implementation process of eHealth ... 27
4.1.4.1.
Influence of Covid-19 on the implementation process ... 27
4.1.4.2.
External help received during the implementation ... 28
4.1.4.3.
Barriers and process improvement for implementations ... 28
4.2.
Cross-border cooperation ... 29
4.2.1.
Cross-border cases ... 29
4.2.2.
Cross-border learnings ... 30
4.3.
Meaning of eHealth in HCSs and motivation for the use of eHealth ... 31
5.
Discussion ... 33
5.1.
Main results ... 33
5.2.
Sustainability of eHealth offers ... 33
5.3.
Acceptance of eHealth ... 35
5.3.1.
The role of acceptance factors regarding sustainable use of eHealth ... 36
5.3.2.
The role of different technologies ... 37
5.3.3.
Other barriers for sustainable use ... 38
5.4.
Interpretation of Covid-19’s influence on the implementation process ... 39
5.5.
Interpretation of the cross-border findings ... 40
5.6.
eHealth in the context of operations and supply chain management ... 41
5.7.
Limitations and Implications ... 43
vi
List of Figures
Figure 1: Derivation of the research objectives ... 11
Figure 2: eHealth categorized into the framework of De Vries and Huijsman, 2011 ... 42
List of Tables
Table 1: Overview of eHealth implementation barriers in literature ... 8
Table 2: Overview of interviewees ... 15
Table 3: Explanation of the coding tree ... 18
Table 4: Validity & reliability criteria ... 19
Table 5: Overview of influencing factors on eHealth acceptance... 25
Table 6: Application areas of eHealth of Ohannessian, 2015 and this study findings ... 34
Table 7: Factors for a sustainable eHealth implementation of Bradford et al., 2016 ... 35
Table 8: Overview of the Covid-19 influence on implementation barriers ... 40
List of Abbreviations
1
1. Introduction
The current Covid-19 pandemic is challenging different industries around the world. Closed
restaurants have meant that the gastronomy industry is struggling. Commercial flights have
been lowered to a minimum and the oil price went below zero. In these exceptional times,
personal contact has been limited as much as possible. In multiple countries it is forbidden to
leave the house and “social distancing” has been introduced, which includes 1,5m between
individuals to avoid further infections. Reduced personal contact has led to changes in the
business world.
Especially, the health care systems (HCS) around the globe have been pushed to their limits.
With worldwide over 64 million infected people and 1.5 million deaths due to Covid-19
(03.12.2020), the whole medical sector is focusing on the control and treatment of the new virus
(Johns Hopkins University & Medicine, 2020). Multiple countries have extended their expenses
into their HCS. Germany, for example, has spent an extra €30,000 more per bed to provide
increased capacity of intensive care beds (ICB) (Geinitz, 2020). The risk of infection for health
care professionals is extremely high since many are in close contact with Covid-19 patients
daily. Technology could be beneficial in the health sector by reducing the need for face-to-face
contact and consequently lowering the infection risk for professionals (Bashshur et al., 2020).
The digitalization of health care (HC) has been regarded as a promising tool for more than two
decades (Tensen et al., 2016). eHealth technology is considered an efficient way to improve
issues including the increasing costs and long waiting lists seen in many HCSs (Kierkegaard,
2013). The World Health Organization (WHO) considers eHealth to be a mechanism to provide
universal HC coverage, and encourages its member states to implement digital infrastructure
(WHO, 2017). The EU claims that eHealth infrastructure is “one of the European Commission's
main priorities” (European Commission, 2020, p. 1). They developed an action plan to
implement Europe-wide infrastructure which would ensure secure access and exchange of
health data. Although, the concept of eHealth is generally supported, it has received some
criticism. Experts of the European Society of Cardiology have requested for more large-scale
evidence (Cowie et al., 2016).
2
of eHealth a success or a failure (Ross et al., 2016). Among the most commonly identified
barriers to eHealth implementation were the governmental regulations which bring about
innovation inhibition, and data protection concerns were also identified as barrier to overcome
(Anaya et al., 2018).
Interestingly, since the beginning of the Covid-19 pandemic, digitalization seems has sped-up.
Many people have been forced to work from home to avoid contact with others, and as a result
digital communication has increased (PwC Strategy&, 2020). One region in Norway registered
a rise of video-consultancy by 350% in March (Rolf, 2020) and in some HSCs the regulations
have changed. In Germany, it was possible to request sick leave via phone from February until
May, and this is also possible during the current second wave from October to at least the end
of 2020 (Bundesregierung, 2020). In addition, the German government enacted a law to force
hospitals to share daily updates about their free ICB on a platform for a better coordination of
infected people (dpa, 2020). Different countries have shared their free capacities with those
countries in need. For example, Germany treated Dutch patients in their hospitals (von Dewitz,
2020). The need for cross-border communication seems to be an increasingly important topic
in HC, and for politicians. The Covid-19 pandemic could influence the speed of eHealth
implementation. This is also indicated by the increasing call for more eHealth to aid the fight
against Covid-19 in the newest literature (Ohannessian et al., 2020).
3
2. Theoretical Background
2.1. Definition
2.1.1. eHealth
According to the WHO, electronic health (eHealth) is the “use of information and
communication technologies […] for health” (WHO, 2020). This definition has been adopted
by others, for example by Blaya et al. (2010). In a highly respected review to define “eHealth”,
Oh et al. (2005) found that most definitions include the words “health” and “technology”, or
more explicitly the word “internet”. eHealth has often been identified as a tool to overcome
barriers, such as long distance. Eysenbach (2001) regards eHealth as “a state of mind, a way of
thinking”. In his definition “e” not only stands for “electronic”, but also for numerous other
words, which is why his definition is broad. Nevertheless, in most publications eHealth implies
the use of technology in healthcare.
This technology can be categorized into two different categories. Firstly, the technology needed
for a patient’s treatment, for example video-consultancy. This is the wireless treatment of
patients via a video-tool. Secondly, the technology that is being used within an organization to
improve the administrational work. For example, a software to save files electronically in order
to operate paperless. The usage and benefits of eHealth were noted in the early work from Ball
and Lillis (2001), who stated that costs could be reduced via electronic communication. As a
result, money could be saved and the outcome could be increased. More recent publications
also highlight the benefits of the use of eHealth in HC. In particular, the area of psychology has
received the attention of eHealth studies (Bennett et al., 2020).
2.1.2. mHealth
4
Kumar et al. (2013) found benefits such as reduced costs and improved well-being when
investigating the use of mobile and wearable technology. Catalani et al. (2013) published a
study about mHealth for HIV treatment and prevention and found evidence for a link between
mHealth and improved care.
2.1.3. Wearables
A new trend within the mHealth sector are wearables, such as smartwatches, as “non-invasive
alternatives for continuous 24-h monitoring of health, activity, mobility, and mental status”
(Chan et al., 2012, p. 138). The constant monitoring of a patient can assist a patient or a MP
with (self-) diagnosis and can enable changes in behavior (Piwek et al., 2016). Wearables often
have a wireless connection to a smartphone, which can be via Bluetooth or the internet. When
it comes to monitoring patients in HC, wearables have proved to be useful for long-term
tracking and they have the potential to detect diseases at an early stage. This is evident in a
publication by Arora et al. (2014) regarding Parkinson’s disease. They used smartphones as
inexpensive tools to measure the movement behavior of individuals diagnosed with Parkinson’s
disease in order to identify key indicators for early detection of Parkinson’s symptoms.
Wearables can also provide the opportunity to self-monitor human vital signs, for example
blood pressure (Dias and Paulo Silva Cunha, 2018). As a result, wearables can increase the
availability of treatment and reduce the associated cost, while improving hypertension rate
(Shimbo et al., 2015).
2.2. Development of eHealth
5
Smartphone applications have various features for example, counting daily steps, tracking
sleep, planning personalized workouts, or reminding patients to take medication.
In recent years, modern wearables have attracted significant interest from private consumers.
Supported by the connection to the smartphone, GPS tracking, and the new possibility to
monitor heartrate at the wrist, wearable sales increased from 28,8 million units sold in 2015 to
336,5 million in 2019 (IDC, 2020). The size of the wearables market is expected to be worth
$18.9 billion in 2020, which would be an increase of 30% due to the recent Covid-19 pandemic
(Statista, 2020a). In their review about the reliability of commercial wearables, Fuller et al.
(2020) found that the devices can accurately measure steps and heart rate, but this varies by
brand and manufacturer. However, the accuracy has been demonstrated in laboratory
conditions, and Fuller et al. (2020) consequently call for further research as the devices are
developing rapidly. This reliability issue is one example of a barrier in adopting eHealth in the
HCSs (Harrison and Lee, 2006; Dundon et al., 2020). The next chapter will review this situation
in more detail.
2.3. The German and Dutch HCS
2.3.1. The HCSs of Germany and the Netherlands
While the consumer sector has rapidly increasing demand for digital health products, the
demand in the HCS has developed more slowly. Only 73 of the WHO member states had an
eHealth strategy in place in 2017 (WHO, 2017). This is despite the WHO’s existing resolution
to implement an eHealth strategy, in which they acknowledged the potential positive impact of
communication technology on HC (WHO, 2005). The following chapter will briefly introduce
and compare the German and the Dutch health systems, followed by a presentation of the
current progress regarding eHealth in both HCSs.
6
In comparison, in the German HCS the decision power is divided between the federal and state
governments, making the process and reform more complicated (Blümel and Busse, 2020). The
interests of not only the federal government, but also of the 16 states have to be considered in
the process and a compromise, acceptable for all parties, must be agreed upon. Unlike the Dutch
system, Germany does not have a gatekeeper system. In Germany, it is possible to directly visit
a specialist, which leads to longer waiting times for an appointment. In the German HCS two
different kind of health insurances exist: the statutory health insurance and private health
insurance. The latter can only be chosen when a person’s income surpasses a certain boundary
(€56,250) (Blümel and Busse, 2020). Dutch citizens do not have priority over other patients
when having an additional private insurance. In contrast, German citizens with private health
insurance are often prioritized, leading to increased waiting times for statutory insured patients.
Even though the insurance is different, the providers are the same for both (Kornelius and
Langner, 2020).
When it comes to insurances and the coverage of costs, the Dutch have more freedom to choose
their degree of coverage. The costs for basic insurance in the Netherlands are relatively low and
roughly the same for everyone. Citizens with low income receive government support to pay
their medical insurance. In Germany, the costs are related to a person’s income, but basic
insurance in Germany covers more treatments and additional insurance is often not needed.
For treatments not covered by their own IC, people will want to keep the costs as low as
possible. Since eHealth is associated with more efficiency and lower costs, the adoption of
eHealth might be influenced by the degree of insurance coverage of a person, or a countries
population. In this case, the Dutch would have more flexibility about how much to spend on
insurance and what to cover (Blümel and Busse, 2020; Wammes et al., 2020).
2.3.2. Progress of eHealth in the HCSs
7
the first plans to implement it (Fricke, 2020). According to the Future Health Index, only 64%
of MPs in Germany use any digital health technology (Koninklijke Philips N.V., 2019). While
only 53% of young MPs see an advantage in the usage of eHealth, while the average of 15
countries is 74% (Koninklijke Philips N.V., 2020).
The Dutch government is currently pursuing similar goals. Dutch MPs keep electronic patient
files which are accessible to the patient (Netherlands Enterprise Agency, 2020). In addition,
they try to support instruments for self-measurement and further promote the video-consultancy
(Government of the Netherlands, 2015). Similar to the German government, the Dutch
government is struggling with the implementation process due to concerns over privacy and the
fragmentation of HC stakeholders (Eerste Kamer der Staten-Generaal, 2011). However, in an
international context, the digitalization of the Dutch HCS is highly developed. For example, on
average, a Dutch GP has twelve video-consultations per day (Daley et al., 2013).
2.3.3. Cross-border cooperation between Germany and the Netherlands
The HC cooperation between Germany and the Netherlands is supported by the EU through the
Interreg program, which spent €9.0 billion between 2014 and 2020 on cross-border cooperation
in Europe (Interreg, 2020a). Among the supported projects are multiple in the field of HC. The
IZOM (Integratie Zorg Op Maat) project, for example, aimed to ease patient movement between
Belgium, Germany, and the Netherlands, and was supported with €2.7 billion. Telemedicine
implementation was supported in the border area between Germany and Poland in order to
move data, but not patients, between 2007 and 2013. To encourage the cooperation between
hospitals, €500,000 were used for the collaboration between a German and a French hospital
between 2007 and 2013 (Delecosse et al., 2017). The EU is currently supporting projects and
studies in the German-Dutch border area with “Interreg Deutschland Nederland”. The volume
is estimated to be €400 million for the time between 2014 and 2020 (Interreg, 2020a). The
self-claimed program objective is “to increase the innovative capacity of the border region and to
reduce the barrier effect of the boundary” (Interreg, 2020a, p. 1), while the goals with highest
priority are innovation in SME, and energy and low carbon economy.
8
transport patients at the end of October (Behrendt, 2020; Meissner, 2020). To improve patient
movement and information flow between different countries, projects such as those supported
by Interreg are now even more valuable for the EU.
2.4. Drivers and barriers of eHealth implementation
A large amount of research exists regarding the drivers and barriers of eHealth implementation
(Niknejad et al., 2020). No single factor is responsible for the failure or success of eHealth
adaption (Ross et al., 2016). Some factors are more obvious, such as the reliability of
technology (Harrison and Lee, 2006; Tison et al., 2018; Dundon et al., 2020), the training of
staff to handle eHealth equipment (Harrison and Lee, 2006; Ross et al., 2016; Morilla et al.,
2017) and the digital divide caused by different accessibility of technology such as the internet
(Yamin et al., 2011). To overcome the first-mentioned barrier is a question of time and the
second one comparably easy to tackle when identified. The need for structural change of an
organization and the lack of infrastructure for adequate technology usage is more difficult to
successfully overcome (Gleason, 2015; Nohl-Deryk et al., 2018; Dundon et al., 2020).
Overcoming these barriers requires immense effort and is especially difficult when the
infrastructure also includes individuals from outside a company. A part of this barrier is the
challenge to manage big data for efficient use of valuable information (Krey, 2020).
Barrier
Explanation
Identified by
Lack of policy
support
Clear regulations are missing,
which inhibits the
implementation
Akter and Ray (2010); Kaye et al.
(2010); Ross et al. (2016); Morilla et
al. (2017)
Data protection
MPs and patients are concerned
about the security of patient
data
Gleason (2015); Ross et al. (2016);
Anaya et al. (2018)
Lack of digital
infrastructure
The infrastructure and
connectivity between system is
insufficient
Gleason (2015); Nohl-Deryk et al.
(2018); Dundon et al. (2020)
Reliability of
technology
eHealth devices are not ready
for the market
Harrison and Lee (2006); Tison et al.
(2018); Dundon et al. (2020)
Big data
management
The amount of data needs to be
handled in an efficient way
Krey (2020)
Training of MPs
MPs need training to adapt
oneself to new technology
Harrison and Lee (2006); Ross et al.
(2016); Morilla et al. (2017)
9
The barriers which are identified most often are arguably, the lack of policy support and data
protection concerns related to health information (Akter and Ray, 2010; Kaye et al., 2010;
Gleason, 2015; Ross et al., 2016; Morilla et al., 2017; Anaya et al., 2018). The lack of policy
support relates to the enacting of laws to facilitate implementations, the financial funding for
eHealth projects and the management of different stakeholders of the HCS. The data protection
concerns are mainly driven by the patients and MPs.
2.5. eHealth during pandemics
For HCSs around the world, eHealth has proven to be valuable for the management of HC
during different pandemics. During the outbreak of SARS-CoV as well as Zika Virus in Africa
technology proved itself to be useful (Ahmadi et al., 2018; Ohannessian et al., 2020). Also, in
Africa the tracking of confirmed Ebola cases via mobile apps, helped to reduce the spreading
of Ebola, since it was faster than paper-based solutions (Keshvardoost et al., 2020).
Initial Covid-19 studies regarding the use of internet hospital in China, where the Covid-19
virus originated and began to spread, have demonstrated the usefulness of eHealth during this
pandemic. Patients were consulted remotely at home, which prevented overcrowding in the
hospitals and minimized the risk of further infection (Gong et al., 2020; Rockwell and Gilroy,
2020). In another publication, the vital signs of patients in a hospital in Switzerland were
monitored with a smartphone app and it has been evaluated as “an effective and time-saving
communication channel within our institution” (Zamberg et al., 2020, p. 6). The latter two
findings are initial and brief results, which are limited to a short time period and a limited
method or literature base. Nevertheless, findings do indicate the potential benefits of eHealth
in the Covid-19 pandemic. Timmers et al. (2020) evaluated the implementation of an app for
self-monitoring of Covid-19 in the Netherlands over a short period of three weeks. They
successfully linked the data to an interactive map with the aim to gain further insights about the
virus via this eHealth tool.
10
authors strongly recommended “to apply telehealth tools as an appropriate option to prevent
and contain COVID-19 infection” (p. 8). The indication for improvement in HC delivery also
has been stated by Tebeje and Klein (2020), and these authors call for more research about that
topic in the future. So do Smith et al. (2020) in their paper about eHealth in a Covid-19 context.
Even though they state that “Telehealth does have a critical role in emergency responses” (p.
311), they also mention the importance to highlight is limitations and how important it is to
communicate those.
The potential role of eHealth during the Covid-19 pandemic has also been evaluated in a more
specific context of different medical areas. For example, Neubeck et al. (2020) reviewed nine
articles about people living with cardiovascular disease during Covid-19 and found that eHealth
improved the HC for those people. Furthermore, a systematic literature review by Rauschenberg
et al. (2020) identified mHealth as an important tool to provide HC, and Novara et al. (2020)
established eHealth as helpful in the context of urology.
According to Hollander and Carr (2020), the use of technology is not a complete solution but
is well suited for the Covid-19 pandemic. They state that “health systems that have already
invested in telemedicine are well positioned to ensure that patients with Covid-19 receive the
care they need” (Hollander and Carr, 2020, p. 1681). This statement would indicate that the
Netherlands are better prepared than other countries, such as Germany, when taking the Future
Health Index as benchmark. Keesara et al. (2020, p. 1) also suggest the need for more
digitalization in the HCS against Covid-19 when appealing for “unleashing the power of digital
technologies”.
2.6. Research objectives
11
government passed an investment program to digitize hospitals and launched an online platform
to provide serious health information to the population (BMG, 2020b; BMG, 2020a).
The Dutch government provided a grant for GPs to invest in the digital infrastructure of their
practices (RVO, 2020). Furthermore, ICs were allowed to cover additional digital treatments.
The first contact between a patient and a GP, for example, no longer must be face-to-face (NZa,
2020). This might help MPs to overcome their documented lack of willingness to adopt eHealth
in their daily practice (Nohl-Deryk et al., 2018). In addition, the general population may have
overcome their concerns regarding data protection. The German corona app has been
downloaded more than 20 million times by the end of October 2020 (BMG_Bund, 2020). The
pandemic is undeniably a major challenge for the HCS, but it could accelerate change in HC
and lead to improvement in efficiency and quality of care. Wind et al. (2020) stated in their
publication that in multiple countries, the threat of Covid-19 has forced managers to address all
eHealth implementation barriers. Or as Ting et al. (2020, p. 461) wrote in their article: “As the
saying goes, ‘a crisis provides an opportunity’; this first great crisis of 2020 provides a great
opportunity for digital technology.”.
12
The literature regarding Covid-19 is increasing rapidly. A large amount of literature is from a
biological or a medical perspective, such as the influence of the virus on different diseases
(Fang et al., 2020; Zheng et al., 2020), the treatment of Covid-19 (Cascella et al., 2020) and
the containment of further dissemination (Hellewell et al., 2020). Another significant literature
focus is the economic influence of Covid-19 (Fernandes, 2020; Ivanov, 2020). However, many
studies conducted on Covid-19 and eHealth only review previous literature, without collecting
additional data. Sust et al. (2020) take North Spain as a case to illustrate the faster
implementation of eHealth due to Covid-19 using only previous literature. Consequently, the
following master thesis aims to investigate the influence of Covid-19 on the digitalization of
public HCS with a qualitative study and expert interviews to determine whether the pandemic
provides an opportunity for eHealth.
2.6.1. The impact of Covid-19 in different countries
The Covid-19 pandemic has impacted each country in different ways, the actions and further
development of the HCS will differ from country to country. Consequently, this study aims to
measure the impact in two countries – Germany and the Netherlands. These countries are
comparable for various reasons. Firstly, they are neighboring countries, and it is sensible to
compare two areas which are geographically close to each other. Secondly, Germany and the
Netherlands are highly interconnected due the free trade area of the EU. Thirdly, both countries
are among the wealthiest in the world, and they have a similar culture. Germany and the
Netherlands do, however, differ when it comes to HCS. As mentioned previously, the
Netherlands are considered to be a forerunner in the HCS, while Germany is less effective and
less developed in the eHealth area. However, Germany appears to have performed slightly
better than the Netherlands, particularly during the first wave of the Covid-19 pandemic.
According to the Johns Hopkins University & Medicine (2020), Germany had 1,117,953
infected people, of which 17,718 died. This equates to a death rate of 1.6% (03.12.2020). For
the Netherlands it is known that there are 9,645 deaths (03.12.2020), but the actual number of
infected people is difficult to determine since the Netherlands did not test as extensively as
Germany in the beginning (Stafford, 2020). It can be assumed that the actual death rate of the
Netherlands is similar to the German rate.
13
countries. It is plausible that these differences may also influence the further development of
the actions of these countries during and after the Covid-19 pandemic. For this reason, it is
necessary to compare Germany and the Netherlands in the present study. Also the cooperation
of both countries appears to be relevant to successfully manage the Covid-19 pandemic. Since
the start of the pandemic, Germany used its high capacity of ICB to support other countries and
treated over 200 foreign patients (Auswärtiges Amt, 2020a). This kind of support may be crucial
in the near future.
2.7. Research Questions
In order to determine whether the Covid-19 pandemic provides an opportunity for eHealth and
the cooperation between Germany and the Netherlands, the research question will be the
following:
“How do German and Dutch medical professionals see the influence of Covid-19 on
eHealth and cross-border cooperation?”
There are supportive questions which are formulated to help answering the main questions of
the research. The first question aims to identify changes in the daily operation of the stakeholder
and tries to identify if these changes were faced with eHealth. Secondly, the thesis question
asks for influencing factors in the opinion of the interviewees. In this way, the research aims to
identify factors having an impact on the acceptance of eHealth. The third supportive question
aims to analyze the implementation process and find out whether or not the implementations
took place faster. Finally, the cooperation between the two introduced countries is treated in
order to identify cooperation, the role of eHealth and the future plans of the stakeholders.
I.
What change did the MP’s experience in their operation during Covid-19 and how
was it related to eHealth?
II.
What factors are relevant for stakeholders of the HSCs regarding the acceptance of
eHealth?
III.
How did Covid-19 influence the implementation processes of eHealth?
14
3. Methodology
3.1. Case selection
This study follows an inductive approach, since the master thesis will build a theory from
observed phenomena, such as the increased call for eHealth implementation, and politicians
being forced to act. To conduct this cross-border case study, MPs have been interviewed to
gather qualitative data. Interviews with eleven MPs have been conducted to ensure a sufficient
amount of data.
Inclusion criteria were used to select interviewees. Firstly, participants must operate within the
border area defined by Interreg project (Interreg, 2020b). A total number of seven interviewees
are from Germany, while four are from the Netherlands. According to Gläser and Laudel
(2009), an expert has to have a special standing in the research context. To ensure more than
one point of view was covered in the context of HCSs, and that valuable information was not
missed, the experts are represented by different stakeholders of the HCS (see Table 2). Every
interviewee has at least 10 years of working experience in their profession.
The GPs have been chosen because they are in the center of the HCS and can experience rapid
change in the way they work. Therefore, their input has created valuable information about
eHealth in their practice. Other experts with a special standing in the system and who experience
change in HCS are ICs. ICs can have a huge influence with their policies. For example, tools
and technology that are supported or paid by ICs are more likely to be used by patients and
prescribed by a doctor. Therefore, ICs can encourage eHealth implementation when
recommending eHealth products. Changes of policies and set-up of programs during the
Covid-19 pandemic suggest the need for an increased digital HSC.
15
Name Profession
Job
experience
Country
Interview
form
Age
I1
Insurance manager
11 years
Netherlands
Video-call
31-40 years
I2
GP
12 years
Germany
Video-call
31-40 years
I3
Hospital manager
30 years
Germany
Telephone
51-60 years
I4
GP
19 years
Netherlands
Video-call
41-50 years
I5
Physiotherapist
16 years
Germany
Telephone
31-40 years
I6
Insurance manager
>30 years
Germany
Video-call
51-60 years
I8
Insurance manager
30 years
Germany
Video-call
51-60 years
I9
GP
30 years
Germany
Video-call
51-60 years
I10
Insurance manager
20 years
Netherlands
Video-call
41-50 years
I11
GP
-
Netherlands
Telephone
-
I12
Head of psychology 12 years
Germany
Video-call
41-50 years
Table 2: Overview of interviewees
3.2. Data collection
Interviews were used to collect data based on a semi-structured interview guide (see Appendix
A). This interview type is flexible and gives the interviewer the opportunity to ask follow-up
question to gain further details. It also gives the interviewer the chance to explain unclear
questions (Gläser and Laudel, 2009). The interviews focused on experts in order to gain
knowledge about their experience with eHealth during the Covid-19 pandemic. The interview
guides were very similar, however, for the interviewees from ICs, the questions were adjusted
slightly to provide an optimal fit to the interviewees. The interviews were mostly performed via
video-call. Compared to other options, video-calls provided the opportunity to see the other
person which allowed the interviewer to have more control over the conversation, and interpret
the body language of the interviewee (Gläser and Laudel, 2009). Due to the Covid-19 pandemic,
personal contact in face-to-face interviews, as well as travelling across borders, was not an
option. Three interviews were conducted via telephone due to a lack of appropriate technology.
In all interviews, only the interviewee and the interviewer were present. Interviews with
German participants were held in the German language, while interviews with Dutch
respondents were held in English.
The interviews took place between the 18
thof September and the 21
stof October. All interviews
16
The form contained how the confidentiality and anonymity has been ensured (see Appendix B).
The interviewees were given the opportunity to read the consent form and ask questions before
signing the document. Audio recordings of the interviews were taped for multiple reasons.
Firstly, it ensured highly detailed and accurate reconstruction of the interviews. Secondly,
during the interview the interviewer was able to focus on the interview itself and analyze the
situation to ask follow-up questions, and the flow of the interview was not disturbed by taking
notes (Gläser and Laudel, 2009).
At the end of each interview, interviewees had the opportunity to ask for a copy of the transcript
of the recording. This gave the experts the opportunity to check and evaluate their responses,
and it also meant that the interviewer might gain additional knowledge (Gläser and Laudel,
2009). For example, after one interview, the questions regarding cross-border treatment were
sent to a colleague of the interviewee. This made it possible to gain more valuable and additional
information since the interviewee could not provide the needed information.
3.3. Data analysis method
The interviews were transcribed from the recorded audio file to save the data in a reasonable
format (Kaiser, 2014). The coding of the material followed the approach of Gläser and Laudel
(2009) which has the advantage of being flexible to work with. A search grid with different
categories based on theoretical knowledge was created to categorize the data from the
extraction. Then, the text was separated into different phrases and sentences which include
statements with valuable information. The text parts were assigned to the categories from the
search grid. While the extraction process took place, the categories have been further developed.
Definitions of existing categories were developed, and categories were created. This ensured
the flexibility of the search grid and made it open to include unexpected information.
17
searching for words and phrases can make it easier to locate connections in the structured data.
There are, however, limitations to the use of NVivo 12. The researcher must learn how to
properly use the software, as a consequence timesaving decreases slightly. Furthermore, the
software cannot interpret the data for the researcher, it can only be used to facilitate the work.
“The general processes of generating categories or taxonomies, assigning meaning,
synthesizing or theorizing […] still rests on the researcher’s shoulders.” (García‐Horta and
Guerra‐Ramos, 2009, p. 163).
Main
category
First level of
sub-category
Second level
of
sub-category
Description of what the
statements/comments of that category
refer to
eHealth
Offers
Since
Covid-19
The different eHealth services offered to
patients and customers since the Covid-19
pandemic started
Barriers
The barriers that impede to offer more
eHealth
Improvement
potential
Areas and ideas of improvement to offer
more eHealth
Acceptance
Since
Covid-19
The acceptance of eHealth since the
beginning of the pandemic and the
development of eHealth acceptance
Factors
Factors that influence the acceptance of
eHealth
Implementation
process
Since
Covid-19
The implementation processes that took
place since the start of the pandemic and
changes in those processes
Improvement
potential
Areas and ideas of improvement to offer
more eHealth
Barriers
Barriers that appeared during
implementation processes
External help External help that had been received
during the implementation processes
Future
Projects
eHealth projects/plans with concrete steps
been taken to realize them
Plans
Intended plans for future eHealth use with
no step taken yet
Predictions
Predictions about the eHealth development
in the HCS
18
eHealth
Motivation
-
The stakeholder’s motivation to implement
and use eHealth
Meaning
-
The meaning of eHealth for the HCS and
the future development of eHealth
Definition
-
What would be defined as eHealth
according to the interviewees
Cross-border
Cases
-
Cross-border patients that the interviewees
have contact with in their work-life
Learnings
-
Things that the own country/HCS can
learn from the other country/HCS
Cooperation &
communication
-
Cross-border cooperation that the
interviewees have or how the
communication takes places
Treatment
- The process of treatment and follow-up
treatment if necessary
Future
- The plans about the management of
cross-border cases and cooperation
Difficulties
- The difficulties that emerge when treating
patients from another country
Operational
Change
since
Covid-19
-
- The changes in the organizations since the
Covid-19 pandemic began
Job
-
- The description about the interviewees,
their positions and their organizations
Table 3: Explanation of the coding tree